Health Streams
AMS sale to H B Fuller approved
Syuhada Zulkifli · 15/08/2026
AMS sale to H B Fuller approved for 715 million pounds, expanding medical earnings before interest.
Philips shareholder to raise stake to 22% as Dutch medical tech firm signals vote of confidence in its strategy.
AMS sale to H B Fuller approved for 715 million pounds, expanding medical earnings before interest.
BD completes enrollment for hernia mesh trial to compare Phasix mesh with standard suture closure for lowering postoperative…
Philips shareholder to raise stake to 22% as Dutch medical tech firm signals vote of confidence in its…
CMS seeks feedback on a proposal to accelerate coverage for breakthrough devices and eliminate long delays in patient…
Health systems choosing to build vs buy software gain integration control, cost savings, and customized oncology tools, making…
Philips partners with six healthcare firms to improve care continuity using wearable devices for patient monitoring at home…
Medtronic expands CE mark for VT ablation treatment with Affera system. Discover how this new heart rhythm therapy…
FDA sets panel for Galleri cancer screening test to review DNA-based blood test for 50+ cancer types. Learn…
Zimmer Biomet's sales force restructuring exceeds expectations, raising sales and earnings expectations for 2026 with a dedicated sales…
Warren Foust is appointed permanent CEO of STAAR Surgical, ending leadership transition after failed Alcon takeover bid.
